SCA
MEDP icon

Snowden Capital Advisors’s Medpace MEDP Stock Holding History

Snowden Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
729
+68
+10% +$31.4K 0.01% 955
2026
Q1 		$317K Sell
661
-121
-15% -$62K 0.01% 1000
2025
Q4 		$439K Sell
782
-74
-9% -$42K 0.01% 869
2025
Q3 		$440K Sell
856
-110
-11% -$48K 0.01% 846
2025
Q2 		$303K Sell
966
-23
-2% -$6.91K 0.01% 1000
2025
Q1 		$301K Buy
989
+322
+48% +$108K 0.01% 973
2024
Q4 		$222K Buy
+667
New +$226K 0.01% 1118
2024
Q3 		– Sell
-555
Closed -$229K – 1246
2024
Q2 		$229K Sell
555
-27
-5% -$10.7K 0.01% 1087
2024
Q1 		$235K Sell
582
-95
-14% -$33.4K 0.01% 1068
2023
Q4 		$208K Buy
+677
New +$183K 0.01% 1067

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Snowden Capital Advisors's MEDP Position: Q2 2026 in Review

Snowden Capital Advisors increased its Medpace (MEDP) stake by 10% in Q2 2026, buying an estimated $31.4K and bringing the position to 729 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #955.

Snowden Capital Advisors first reported a position in MEDP in Q4 2023 and has held it in 10 quarters since. The position peaked at $440K in Q3 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Snowden Capital Advisors held 729 shares of Medpace worth $386K as of Q2 2026.
  • Snowden Capital Advisors bought 68 Medpace shares in Q2 2026, an estimated $31.4K.
  • Medpace made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #955 holding.
  • Snowden Capital Advisors first reported a position in Medpace in Q4 2023 and has held it in 10 quarters since.
  • Snowden Capital Advisors's Medpace position peaked at $440K in Q3 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.